(secondQuint)Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs.

 Patients were not recruited for nor enrolled in this study.

 This study is a retrospective observational study.

 Data from medical records or insurance claims databases are anonymised and used to develop a patient cohort.

 All diagnoses and treatment are recorded in the course of routine medical practice.

.

 Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs@highlight

A retrospective cohort study using the LabRx medical claims database will be performed to address these objectives.

 The primary objective of this project is to examine the background rates of liver function test (LFT) abnormalities in cancer patients treated with tyrosine kinase inhibitors (TKIs).

